Single daily oral dose of gemfibrozil reduces postprandial hyperlipidemia in hyperlipidemic patients

Authors: Descamps O.; Hondekijn J.-C.; Godrie T.; Desager J.-P.; Heller F.R.

Source: Current Therapeutic Research, Volume 59, Number 8, August 1998 , pp. 545-555(11)

Publisher: Elsevier

Keywords: gemfibrozil; hyperlipidemia; postprandial hyperlipidemia; lipoprotein lipase; hepatic lipase

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0011-393X(98)85094-7

Affiliations: 1: aTumor Metabolism Study Group, Hopital de Jolimont, Haine Saint Paul, , Belgium

Publication date: 1998-08-01

• In this: publication
• By this: publisher
• In this Subject: Therapeutics & Alternative Medicine
• By this author: Descamps O. ;  Hondekijn J.-C. ;  Godrie T. ;  Desager J.-P. ;  Heller F.R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers